Colorado finalized the nation’s first prescription drug price cap Oct. 3, establishing an upper payment limit for Enbrel, an autoimmune medication, through the state’s prescription drug affordability review board, according to the board’s website. The rulemaking process began May 23…

Hospitals that serve a high volume of low-income and uninsured patients rely on Disproportionate Share Hospital (DSH) funding to maintain financial stability. A hospital’s DSH percentage is critical for preserving access to the 340B Drug Pricing Program. As healthcare policy continues to…

Amgen launched a direct-to-patient program Oct. 6 to offer its cholesterol medication Repatha at a reduced price. The AmgenNow program will provide Repatha for $239 per month — nearly 60% below the current U.S. list price — to all eligible…

Becker’s asked pharmacy executives from hospitals and health systems, along with academic medical centers and universities across the U.S. to share their biggest growth opportunities.  The 8 executives featured in this article are all speaking at the Becker’s Healthcare Fall…

Costco and Novo Nordisk are teaming up to sell a month’s supply of Ozempic or Wegovy for $499 — a sharp discount for the two GLP-1 medications.  In an Oct. 3 post on X, Novo Nordisk announced the collaboration, which…

Rite Aid has closed its final 89 stores, bringing an end to operations after decades as one of the largest pharmacy chains in the U.S. “All Rite Aid stores have now closed. We thank our loyal customers for their many…

A recently announced initiative between Pfizer and the Trump administration to lower U.S. drug prices will likely have minimal effects at the pharmacy counter, The New York Times reported Oct. 1.  On Sept. 30, Pfizer CEO Albert Bourla, PhD, said…

The FDA approved Evita Solutions’ abbreviated new drug application for mifepristone 200 mg tablets, with the approval taking effect Sept. 30. The product was determined to be bioequivalent and therapeutically equivalent to Danco Laboratories’ Mifeprex 200 mg tablets, according to…

Charlotte, N.C.-based Advocate Health is addressing pharmacy deserts on Chicago’s South Side by installing new medication vending machines, the Chicago Tribune reported Oct. 1. The system recently installed the machines at Advocate Trinity Hospital and Advocate Medical Group’s Imani Village…

Novartis received approval from the Food and Drug Administration for Rhapsido (remibrutinib), an oral treatment for adults with chronic spontaneous urticaria. Rhapsido is the first Bruton’s tyrosine kinase inhibitor approved for the condition, according to a Sept. 30 news release.…